Incidence of nonmelanoma skin cancer in the United States population aged 65 years and older, 2014 - 07/08/21
Doi : 10.1016/j.jaad.2019.08.079
Howard Rogers, MD, PhD a, Mara Beveridge, MD b, ⁎ 
, Jonas Puente, MSc c, Sarah Wixson, PhD, MS c, Bryan Loy, MD c, Laura E. Happe, PharmD, MPH c
, Jonas Puente, MSc c, Sarah Wixson, PhD, MS c, Bryan Loy, MD c, Laura E. Happe, PharmD, MPH c a Advanced Dermatology, Norwich, Connecticut
b Department of Dermatology, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio
c Humana Inc, Louisville, Kentucky
∗Correspondence to: Mara Beveridge, MD, University Hospitals Case Medical Center, 11100 Euclid Ave, Lakeside 3500, Cleveland, OH 44106University Hospitals Case Medical Center11100 Euclid AveLakeside 3500ClevelandOH44106
| Laura Happe is currently at the University of Florida. Jonas Puente is currently at PriceWaterhouseCoopers. Funding sources: None. |
|
| Conflicts of interest: None disclosed. Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 85 - N° 3
P. 741-743 - septembre 2021 Retour au numéro
Article précédent
- High-dose spironolactone for acne in patients with polycystic ovarian syndrome: A single-institution retrospective study
- Pallavi Basu, Scott A. Elman, Boya Abudu, Ashley Beckles, Prerna Salian, Daniel A. Yanes, Martina L. Porter, Rachel V. Reynolds
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Carlos G. Wambier, Brittany G. Craiglow, Brett A. King
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?